Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Adv Healthc Mater. 2019 Jan 29;8(4):e1801425. doi: 10.1002/adhm.201801425

Figure 4.

Figure 4.

Donor-specific FBR of patient PBMC-derived monocytes to the Ti microbeads. a) Monocyte/PET membrane interactions in the absence or presence of HUVECs under static or dynamic conditions. b) Trans-enothelial migration of monocytes onto Ti microbeads in the bottom tissue chamber in the absence or presence of MCP-1 under dynamic conditions. c) Quantification of trans-enothelial migration of monocytes onto Ti microbeads in the bottom tissue chamber in the absence or presence of MCP-1. d) CD206/CD80 expressions of activated monocytes from three different human donors on Ti microbeads in the presence of MCP-1 under dynamic conditions. e) Quantifications of CD206 and CD80 expressions of activated monocytes on the Ti microbeads in the presence of MCP-1 under dynamic conditions for monocytes derived from three different human donors. f) Quantifications of CD206/CD80 expression ratios of activated monocytes on the Ti microbeads in the presence of MCP-1 under dynamic conditions for monocytes derived from three different human donors. *p < 0.05 and **p < 0.01.